Imad Sandid PharmD, PhD

Dr. Imad Sandid, PharmD, Ph.D. in Medical Biology, started his career in 1988 as a hospital laboratory practitioner in medical biology. Since 1992, he has been working in the field of blood transfusion and built up a broad range of expertise, both nationally and internationally. At French National Agency for the Safety of Medicines and Health Products (ANSM), he holds several positions, including team manager for the regulation and traceability of blood components; and national manager of database coding for Blood Establishment codes, blood component codes and biological analysis codes.

He also serves as the project manager for the e-FIT, secure electronic haemovigilance reporting system, and coordination of national vigilance (haemovigilance, medical devices vigilance and in vitro device vigilance); and national haemovigilance officer (since 2008). In addition, Sandid is a board member on the French Advisory Group (FAG), where he is responsible for the surveillance of emerging agents that are potentially transmissible by Substances of Human Origin (Soho). He serves as the national coordinator for annual reports and surveys (European Commission, Council of Europe, WHO and International Haemovigilance Network).